VARIATIONS IN THE EXPRESSION OF CELL-ADHESION MOLECULES ON LIVER-ASSOCIATED LYMPHOCYTES AND PERIPHERAL-BLOOD LYMPHOCYTES IN PATIENTS WITH AND WITHOUT LIVER METASTASIS
M. Garciabarcina et al., VARIATIONS IN THE EXPRESSION OF CELL-ADHESION MOLECULES ON LIVER-ASSOCIATED LYMPHOCYTES AND PERIPHERAL-BLOOD LYMPHOCYTES IN PATIENTS WITH AND WITHOUT LIVER METASTASIS, International journal of cancer, 61(4), 1995, pp. 475-479
We evaluated the expression of the cell-adhesion molecules (CAM) that
might be involved in liver-associated lymphocyte (LAL) contacts with o
ther sinusoidal cells and/or be responsible for natural-killer(NI) and
lymphokine-activated killer(LAK) activity in patients with liver meta
stasis. The LAL population was isolated by sinusoidal high-pressure la
vage from partial hepatectomies obtained from patients operated for me
tastases (n = 13) and benign liver tumors (n = 9). Surface expression
of the beta-2-integrin chains (CD11a, CD11b, CD11c and CD18), and the
beta-1-integrin chains (CD49b, CD49d, CD49f and CD29), as well as that
of members of the immunoglobulin superfamily (CD2, CD54, CD56 and CD5
8), were analyzed by one- or two-color flow cytometry. Quantitative an
d qualitative differences were observed in both groups of patients in
the expression of CAM between LAL and peripheral blood lymphocytes (PB
L). LAL were characterized by an increase in the percentage of CD11b-,
CD49b-, CD49d-, CD54-, CD56- and CD58-positive cells in comparison wi
th PBL. Fluorescence values for CD2, CD11a, CD18 and CD56 were higher
in LAL than in PBL. Moreover, the population expressing these antigens
of differentiation presented a bimodal distribution (dim and bright):
in LAL, as opposed to PBL, the percentage of cells with a bright phen
otype was greater than of those with a dim one. The increase in CAM ex
pression on LAL could be due to the influence of the liver sinusoidal
micro-environment. Results were more unexpected for the comparison bet
ween benign and malignant tumors. No difference was found in CAM expre
ssion on LAL between these 2 categories. Consequently, it cannot be th
is factor that explains the decrease in LAK activity of LAL in patient
s with metastasis. (C) 1995 Wiley-Liss, Inc.